MedPath

EVUSHELD 150 MG +150 MG SOLUCION INYECTABLE

EVUSHELD 150 MG +150 MG SOLUCION INYECTABLE

Pending
Register Number

1221651001

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Mar 31, 2022

Dosage Form

SOLUCIÓN INYECTABLE

Route: VÍA INTRAMUSCULAR

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1221651001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (2)

CILGAVIMABActive
Quantity: 150 mg
Name: CILGAVIMAB
TIXAGEVIMABActive
Quantity: 150 mg
Name: TIXAGEVIMAB

ATC CLASSIFICATION (3)

J06B
J06BD
J06BD03

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.